These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27806846)

  • 1. Gastric mixed adenoneuroendocrine carcinoma: correlation of histologic characteristics with prognosis.
    Nie L; Li M; He X; Feng A; Wu H; Fan X
    Ann Diagn Pathol; 2016 Dec; 25():48-53. PubMed ID: 27806846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of neuroendocrine components in gastric carcinomas.
    Park JY; Ryu MH; Park YS; Park HJ; Ryoo BY; Kim MG; Yook JH; Kim BS; Kang YK
    Eur J Cancer; 2014 Nov; 50(16):2802-9. PubMed ID: 25201164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Biliary Mixed Adenoneuroendocrine Carcinoma (MANEC): A Short Review.
    Acosta AM; Wiley EL
    Arch Pathol Lab Med; 2016 Oct; 140(10):1157-62. PubMed ID: 27684986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: report of two cases.
    Gurzu S; Kadar Z; Bara T; Bara T; Tamasi A; Azamfirei L; Jung I
    World J Gastroenterol; 2015 Jan; 21(4):1329-33. PubMed ID: 25632209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal: Gastric mixed adenoneuroendocrine carcinoma.
    Furukawa K; Miyahara R; Funasaka K; Asai H; Hirooka Y; Goto H
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1236. PubMed ID: 26825751
    [No Abstract]   [Full Text] [Related]  

  • 6. Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity.
    Sahnane N; Furlan D; Monti M; Romualdi C; Vanoli A; Vicari E; Solcia E; Capella C; Sessa F; La Rosa S
    Endocr Relat Cancer; 2015 Feb; 22(1):35-45. PubMed ID: 25465415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients.
    Xie JW; Lu J; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Li P; Huang CM
    BMC Cancer; 2018 Oct; 18(1):1021. PubMed ID: 30348122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers.
    La Rosa S; Marando A; Furlan D; Sahnane N; Capella C
    Am J Surg Pathol; 2012 Apr; 36(4):601-11. PubMed ID: 22314183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas.
    Koh J; Nam SK; Kwak Y; Kim G; Kim KK; Lee BC; Ahn SH; Park DJ; Kim HH; Park KU; Kim WH; Lee HS
    J Pathol; 2021 Jan; 253(1):94-105. PubMed ID: 32985687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastrointestinal mixed adenoneuroendocrine carcinomas. An attempt at classification of mixed cancers].
    Reu S; Neumann J; Kirchner T
    Pathologe; 2012 Feb; 33(1):31-8. PubMed ID: 22293787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Outcomes in Patients With Small- and Large-Cell Neuroendocrine Carcinoma (NEC) and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm (MiNEN) of the Stomach.
    Choi NY; Kim BS; Oh ST; Yook JH; Kim BS
    Am Surg; 2021 Apr; 87(4):631-637. PubMed ID: 33142079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal mixed adenoneuroendocrine carcinoma (MANEC): An immunohistochemistry study of 13 microsatellite stable cases.
    Gurzu S; Fetyko A; Bara T; Banias L; Butiurca VO; Bara T; Tudorache V; Jung I
    Pathol Res Pract; 2019 Dec; 215(12):152697. PubMed ID: 31704155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High neuroendocrine component is a factor for poor prognosis in gastrointestinal high-grade malignant mixed adenoneuroendocrine neoplasms.
    Chen MH; Kuo YJ; Yeh YC; Lin YC; Tzeng CH; Liu CY; Chang PM; Chen MH; Jeng YM; Chao Y
    J Chin Med Assoc; 2015 Aug; 78(8):454-9. PubMed ID: 26002564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed Adeno-Neuroendocrine Carcinoma; Case Series of Ten Patients with Review of the Literature.
    Düzköylü Y; Aras O; Bostancı EB; Keklik Temuçin T; Ulaş M
    Balkan Med J; 2018 May; 35(3):263-267. PubMed ID: 29551754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
    Lim SM; Kim H; Kang B; Kim HS; Rha SY; Noh SH; Hyung WJ; Cheong JH; Kim HI; Chung HC; Yun M; Cho A; Jung M
    Ann Nucl Med; 2016 May; 30(4):279-86. PubMed ID: 26837515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms.
    La Rosa S; Inzani F; Vanoli A; Klersy C; Dainese L; Rindi G; Capella C; Bordi C; Solcia E
    Hum Pathol; 2011 Oct; 42(10):1373-84. PubMed ID: 21531442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic outcome of mixed adenoneuroendocrine carcinoma (MANEC): A single center case series.
    Dulskas A; Pilvelis A
    Eur J Surg Oncol; 2020 Jan; 46(1):105-107. PubMed ID: 31444026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of mixed adenoneuroendocrine carcinoma of the stomach with focal intestinal metaplasia and hypergastrinemia.
    Yamauchi H; Sakurai S; Nakazawa N; Yoshida T; Tabe Y; Saitoh K; Fukasawa T; Kiriyama S; Naitoh H; Kuwano H
    Int Surg; 2015 Mar; 100(3):562-7. PubMed ID: 25785345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal and molecular pathway alterations in the neuroendocrine carcinoma and adenocarcinoma components of gastric mixed neuroendocrine-nonneuroendocrine neoplasm.
    Sun L; Zhang J; Wang C; Zhao S; Shao B; Guo Y; Liu Y; Sun Y
    Mod Pathol; 2020 Dec; 33(12):2602-2613. PubMed ID: 32461621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
    Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
    Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.